2009
DOI: 10.1016/j.ejpb.2008.12.001
|View full text |Cite
|
Sign up to set email alerts
|

A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
73
0
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 98 publications
(75 citation statements)
references
References 38 publications
1
73
0
1
Order By: Relevance
“…This study found that freeze-drying was an efficient method to dry phages with little decrease in phage activity, which would help in developing different paper-coating approaches for the commercial manufacture of phage-containing bioactive membranes. The same technique has been used for the encapsulation of Staphylococcus aureus and Pseudomonas aeruginosa phages without affecting their lytic activity (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…This study found that freeze-drying was an efficient method to dry phages with little decrease in phage activity, which would help in developing different paper-coating approaches for the commercial manufacture of phage-containing bioactive membranes. The same technique has been used for the encapsulation of Staphylococcus aureus and Pseudomonas aeruginosa phages without affecting their lytic activity (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…Однако исследования микрокристаллов и микросфер не показывают значительных результатов, так как при хранении происходит потеря титра относительно быстро (не более 6 недель при 4⁰C) [41][42][43].…”
Section: микрокристаллы и микросферыunclassified
“…Puapermpoonsiri et al [56] showed that the stability of the bacteriophage in the nasal inserts was far greater than for encapsulated phage in polyestermatrices, wherein no lytic activity was observed after 1 week and Wright et al [57] showed that the bacteriophage titer in the inserts after 12 months may still represent a therapeutic dose. The first controlled clinical trial of a therapeutic bacteriophage preparation showed efficacy and safety in chronic otitis because of chemo-resistant P. Aeruginosa [56]. Following bacteriophage therapy of methicillin-resistant Staphylococcus aureus with a nasal insert was studied by Alfadhel et al [58].…”
Section: Overview Of Work On Nasal Insertsmentioning
confidence: 99%
“…Bacteriophage include nasal delivery was studied by some researhers [56][57][58]. Puapermpoonsiri et al [56] showed that the stability of the bacteriophage in the nasal inserts was far greater than for encapsulated phage in polyestermatrices, wherein no lytic activity was observed after 1 week and Wright et al [57] showed that the bacteriophage titer in the inserts after 12 months may still represent a therapeutic dose.…”
Section: Overview Of Work On Nasal Insertsmentioning
confidence: 99%
See 1 more Smart Citation